Global Herbicides Market to 2022 - $36 Bn Opportunity Analysis And Industry Forecasts
Oct 18, 2017 11:16 am UTC| Business
Dublin, Oct. 18, 2017 -- The "Herbicides Market - Global Opportunity Analysis And Industry Forecast (2017-2022)" report has been added to Research and Markets' offering. Global herbicides market is...
Oct 18, 2017 11:13 am UTC| Business
Dublin, Oct. 18, 2017 -- The "Global Self Injection Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering. ...
Novan Acquires IP Rights to Treat Viral Malignancies with Nitric Oxide
Oct 18, 2017 11:05 am UTC| Business
Expanded Indications in Field of Virology Build on SB206 Clinical Success Against Human Papillomavirus Company Doses First Patient in Inflammatory Skin Disease Program in Phase 1b Psoriasis Trial with SB414 MORRISVILLE,...
QuickLogic Announces Timing of Third Quarter 2017 Financial Results Conference Call
Oct 18, 2017 11:05 am UTC| Business
SUNNYVALE, Calif., Oct. 18, 2017 -- QuickLogic Corporation (NASDAQ:QUIK), a developer of ultra-low power multi-core voice-enabled SoCs, embedded FPGA IP, display bridge and programmable logic solutions, has scheduled a...
ParkerVision Enters into Common Stock Purchase Agreement with Aspire Capital Fund
Oct 18, 2017 11:01 am UTC| Business
JACKSONVILLE, Fla., Oct. 18, 2017 -- ParkerVision, Inc. (Nasdaq:PRKR) (“ParkerVision” or “Company”), a developer and marketer of semiconductor technology solutions for wireless applications today announced that it has...
Nexeo Solutions to Be Commercial Source For The Mackstat® And Paragon® Preservatives
Oct 18, 2017 11:01 am UTC| Business
THE WOODLANDS, Texas, Oct. 18, 2017 -- Nexeo Solutions, Inc. (NASDAQ:NXEO) announced they will be the commercial source for Mackstat® and Paragon® Preservatives product line globally. This decision comes as a result of...
Edge Therapeutics Announces Third Quarter Financial Results Conference Call on November 1, 2017
Oct 18, 2017 11:01 am UTC| Business
BERKELEY HEIGHTS, N.J., Oct. 18, 2017 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...